Xyrem® (sodium oxybate) – First-Time Generic
January 17, 2017 – The FDA announced the approval of an AA-rated generic version of Jazz Pharmaceuticals’ Xyrem (sodium oxybate) oral solution for the treatment of cataplexy in narcolepsy and for the treatment of excessive daytime sleepiness (EDS) in narcolepsy.
Top